First-Line Afatinib in EGFR NSCLC Patients With Brain Mets First-Line Afatinib in EGFR NSCLC Patients With Brain Mets
A new study looks at the effectiveness of first-line afatinib for patients with EGFR-mutated NSCLC and brain metastasis in a real-world setting.Translational Lung Cancer Research (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - August 7, 2023 Category: Pathology Tags: Hematology-Oncology Journal Article Source Type: news
Capturing the Brain Tumor Microenvironment with Tissue Engineering
Researchers built a 3D glioblastoma model to study therapeutic resistance and improve drug screening systems. (Source: The Scientist)
Source: The Scientist - August 4, 2023 Category: Science Tags: News & Opinion Source Type: news
At age 29 I've survived terminal brain cancer, blood cancer AND a near-fatal car crash
Aria, from Los Angeles, was diagnosed with non-Hodgkins lymphoma, a blood cancer, and underwent 16 brutal surgeries and multiple rounds of chemo, starting her ordeal. (Source: the Mail online | Health)
Source: the Mail online | Health - August 3, 2023 Category: Consumer Health News Source Type: news
Biodegradable ultrasound opens the blood-brain barrier
A new, biodegradable ultrasound far more powerful than previous devices could make brain cancers more treatable, University of Connecticut researchers report in Science Advances. The study was supported by the U.S. National Science Foundation. When … (Source: NSF News)
Source: NSF News - August 3, 2023 Category: Science Authors: NSF Source Type: news
Documentary Community Pays Tribute to Jess Search, ‘Virunga’ Producer and Co-Founder of Doc Society: She ‘Defined Being a Luminary’
Messages have been pouring in to pay tribute to Jess Search, producer and co-founder of U.K.’s Doc Society, who died Monday from brain cancer at the age of 54. Search was a founding director of Doc Society, the mission of which is to “unleash the transformational power of documentary film to…#jesssearch #docsociety #channel4 #shootingpeople #ippr #idfa #skollworldforum #docsocietysgoodpitch #virunga #chechnya (Source: Reuters: Health)
Source: Reuters: Health - August 3, 2023 Category: Consumer Health News Source Type: news
Jess Search, Doc Society Co-Founder, Dies at 54
Jess Search, producer and co-founder of U.K.’s Doc Society, has died. She was 54. Search died in London on July 31 following a brain tumor diagnosis in early June. Search was a near two-decade member and co-founder of the U.K. based Doc Society, a non-profit organization started in 2005 dedicated…#jesssearch #docsociety #docsocietys #todayiam #maxyne #megha #shanida #garysnyder #virunga #livingwithtudors (Source: Reuters: Health)
Source: Reuters: Health - August 2, 2023 Category: Consumer Health News Source Type: news
At age 28 I've survived terminal brain tumor, blood cancer AND a near-fatal car crash... that's why I call myself the 'CEO of not dying'
Aria, from Los Angeles, was diagnosed with non-Hodgkins lymphoma, a blood cancer, and underwent 16 brutal surgeries and multiple rounds of chemo, starting her ordeal. (Source: the Mail online | Health)
Source: the Mail online | Health - July 27, 2023 Category: Consumer Health News Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong growth in both divisions ’ base business; Group sales and profit reflect declining demand for COVID-19 products
Excluding COVID-19 products,Groupsales increase strongly by 8%1at constant exchange rates (CER)In line with the expected declining demand for COVID-19 products,Groupsales decrease 2% (-8% in Swiss francs)Pharmaceuticals Division sales grow strongly by 8% due to continued high demand for newer medicines; new eye medicine Vabysmo is the strongest growth driverDiagnostics Division ’s base businesscontinues its good growth momentum with an increase of 6%, while total divisional sales are 23% lower due to exceptionally high demand for COVID-19 tests in the first half of 2022Core earnings per share decrease 5%, driven by lower...
Source: Roche Investor Update - July 27, 2023 Category: Pharmaceuticals Source Type: news
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong growth in both divisions ’ base business; Group sales and profit reflect declining demand for COVID-19 products
Basel, 27 July 2023Excluding COVID-19 products,Groupsales increase strongly by 8%1at constant exchange rates (CER)In line with the expected declining demand for COVID-19 products,Groupsales decrease 2% (-8% in Swiss francs)Pharmaceuticals Division sales grow strongly by 8% due to continued high demand for newer medicines; new eye medicine Vabysmo is the strongest growth driverDiagnostics Division ’s base businesscontinues its good growth momentum with an increase of 6%, while total divisional sales are 23% lower due to exceptionally high demand for COVID-19 tests in the first half of 2022Core earnings per share decrease ...
Source: Roche Media News - July 27, 2023 Category: Pharmaceuticals Source Type: news
Visual Hallucinations: Psychiatric vs. Neurologic Causes Visual Hallucinations: Psychiatric vs. Neurologic Causes
Visual hallucinations can have a multitude of causes, from psychosis to migraines, brain tumors, neurodegenerative diseases, and more. Review their varying key characteristics in this paper.Current Psychiatry (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 26, 2023 Category: Consumer Health News Tags: Neurology & Neurosurgery Journal Article Source Type: news
AppliedVR touts study in brain tumor patients
AppliedVR said that an interim analysis of a phase II study shows its virtua...Read more on AuntMinnie.comRelated Reading:
Can virtual reality improve the patient experience in MRI?
Virtual reality shows promise for IR training
VR helps burn patients cope with imaging, treatment (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - July 21, 2023 Category: Radiology Source Type: news
GT Medical Technologies Highlights Glioblastoma (GBM) Awareness Day July 19 and Ongoing GammaTile(R) Therapy Clinical Studies
TEMPE, Ariz., July 19, 2023 -- (Healthcare Sales & Marketing Network) -- In 2018, inspired by John McCain's courageous battle with glioblastoma (GBM), a bipartisan group of senators passed a resolution to focus the nation's attention on GBM, which is the ... Devices, Oncology GT Medical Technologies, GammaTile, brain tumor (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - July 19, 2023 Category: Pharmaceuticals Source Type: news
Former Dell exec, wife donate $16.25M to MD Anderson Cancer Center
The Eliases ’ experiences with cancer — including their son's life-saving brain tumor surgery at MD Anderson and the death of Howard’s father due to glioblastoma — drove them to donate for cancer research. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 18, 2023 Category: Pharmaceuticals Authors: Jishnu Nair Source Type: news
Turning up the Heat on Brain Tumors
Oncolytic viruses can help glioblastoma respond to immunotherapy. (Source: The Scientist)
Source: The Scientist - July 17, 2023 Category: Science Tags: News News & Opinion Source Type: news
Consumer Health: What is glioblastoma?
Glioblastoma Awareness Day will be observed Wednesday, July 19, which makes this a good time to learn about one of the most complex, deadly and treatment-resistant cancers. More than 14,490 people in the U.S. will be diagnosed with glioblastoma in 2023, according to the National Brain Tumor Society, and 10,000 people in the U.S. will die of the disease. The five-year survival rate is 6.9%, and the median length of survival is eight months. Glioblastoma, also… (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - July 17, 2023 Category: Databases & Libraries Source Type: news
